News archive

Elisabet Stener-Victorin researches women with polycystic ovary syndrome (PCOS) and was one of the first to notice the disease’s connection with mental illness. Her aim is to understand the causes behind the syndrome and to contribute to better treatment.

Chronic obstructive pulmonary disease (COPD), including chronic bronchitis, causes many deaths and much suffering worldwide. Lena Palmberg has developed lung tissue models to aid understanding of what happens in the body when these diseases strike. The goal is to contribute to the development of new treatments.

Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded this year’s Nobel Prize in Physiology or Medicine is, however, particularly effective in this patient group, research from Karolinska Institutet in Sweden shows. The study is published in the Journal of Medical Genetics.

The Royal Swedish Academy of Sciences has elected two new members – both from Karolinska Institutet. Birgitta Henriques Normark, a professor at the Department of Microbiology, Tumor and Cell Biology, has been elected to the Class for Medical Sciences. Emily Holmes, a professor at the Department of Clinical Neuroscience, has been elected to the Class for Social Sciences.

The Nordic Association for the publication of "Basic & Clinical Pharmacology & Toxicology" has awarded the BCPT Nordic Prize in Basic and Clinical Pharmacology and Toxicology for 2018 to Professor Magnus Ingelman-Sundberg, Department of Physiology and Pharmacology, Karolinska Institutet.

The project "LST-STRATEGY – Strategies for large system transformations in a decentralized healthcare system" led by Monica Nyström at the Department of Learning, Informatics, Management and Ethics, MMC/SOLIID, receives funding from FORTE, the Swedish Research Council for Health, Working Life and Welfare.

Klas Kärre, member of the Nobel Committee and MTC research group leader comments on the on the life-changing possibilities of this year’s Nobel Prize in an interview with freelance journalist Lotta Fredholm.

This year’s Nobel Prize in Physiology or Medicine recognizes the discovery that it is possible to treat cancer by inhibiting the brakes on the immune system. Behind their discovery lies a bold idea and eager basic research, which has led to an entirely new principle for cancer therapy and new medicines that have already been approved. Many factors contribute to rapid developments in this field—in particular, current research at Karolinska Institutet.

The Nobel Assembly at Karolinska Institutet has today decided to award the 2018 Nobel Prize in Physiology or Medicine jointly to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by inhibition of negative immune regulation.